#virologic suppression — Tuesday, September 01, 2026 (1 items)
| 0 | ℹ |
Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study.
(academic.oup.com)
|
Open Forum Infectious Diseases 2026-09-01 | #hiv #virologic suppression #clinical trial |